| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 8,320,000 | 9,154,000 | 8,381,000 | 8,628,000 | | Cost of Revenue | 6,916,000 | 7,326,000 | 6,825,000 | 7,025,000 | | | Gross Profit | 1,404,000 | 1,828,000 | 1,556,000 | 1,603,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 749,000 | 920,000 | 785,000 | 797,000 | | Non Recurring |
-
| 3,060,000 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 655,000 | (2,152,000) | 771,000 | 806,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 8,000 | (34,000) | 45,000 | 5,000 | | Earnings Before Interest And Taxes | 663,000 | (2,186,000) | 816,000 | 811,000 | | Interest Expense | 73,000 | 72,000 | 74,000 | 72,000 | | Income Before Tax | 590,000 | (2,258,000) | 742,000 | 739,000 | | Income Tax Expense | 201,000 | 278,000 | 233,000 | 256,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 389,000 | (2,536,000) | 509,000 | 483,000 | | | Non-recurring Events | | Discontinued Operations |
-
| 3,000 | 3,000 | 12,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 389,000 | (2,533,000) | 512,000 | 495,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $389,000 | ($2,533,000) | $512,000 | $495,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
